Answers are grounded in this paper and cite their sources.
Background Adolescent sexual health interventions seek to reduce sexually transmitted infections (STIs) and unintended pregnancy while improving protective sexual-health behaviors, service use, knowledge, and communication. Recent intervention studies differ substantially in the outcomes they measure, making it important to distinguish direct behavioral or clinical outcomes from service-use and proximal outcomes. Objective To synthesize intervention studies involving adolescents aged 10–19 years and to distinguish direct behavioral or clinical outcomes from service-use and proximal outcomes across global settings. Methods This systematic review was reported in accordance with PRISMA 2020. PubMed, Scopus, CINAHL, and ProQuest were last searched on 15 May 2025 for English-language reports published from 2020 to 2024. Behavioral or clinical, service-use, and proximal outcomes were synthesized separately. Results Fifteen intervention evaluations were included (14 randomized trials and one nonrandomized comparison). Families Talking Together reported lower sexual debut at 12 months (4.7% vs. 14.7%) and higher condom use at last intercourse among sexually active adolescents (74.2% vs. 49.1%). In Zambia, economic support reduced sexual activity versus control (RR = 0.70, 95% CI [0.54, 0.91]), and the combined package reduced sex without condom or contraceptive protection (RR = 0.53, 95% CI [0.37, 0.75]). By contrast, FLASH showed no significant overall behavioral difference, and the Nigerian digital trial showed no significant change in its sexual-behavior index (F = 0.558, p = .572). Several reports measured only service-use or proximal outcomes. Meta-analysis was not conducted because of substantial heterogeneity. Conclusion Evidence of behavioral effectiveness was mixed: selected family-based and economic-support trials reported favorable behavioral effects, whereas other interventions showed null behavioral effects or reported only service-use or proximal outcomes. Heterogeneity, outcome variation, and risk-of-bias concerns limit cross-modality comparisons; improvements in proximal outcomes should not be interpreted as demonstrated reductions in STIs or unintended pregnancy.
No takes yet. Share an insight, caveat, or question.
Pujiati et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: